Background Metastatic breast cancer (MBC) treatment has changed substantially over time,
but we do not know whether survival post-metastasis has improved at the population level …

Cancer recurrence and disease-free survival are key outcomes for measuring the burden of
illness, assessing the quality of cancer care, and informing decisions about increasingly …

Objectives Most population-based cancer databases lack information on metastatic
recurrence. Electronic medical records (EMR) and cancer registries contain complementary …

OBJECTIVE: To describe case mix-adjusted hospital level utilization of minimally invasive
surgery for hysterectomy in the treatment of early-stage endometrial cancer. METHODS: In …

Research in oncology quality of care and health outcomes has been limited by the difficulty
of identifying cancer stage in health care claims data. Using linked cancer registry and …

Purpose Diagnosis of lung cancer at advanced stages can result in missed treatment
opportunities, worse outcomes, and higher health care costs. This study evaluated the wait …

PURPOSE Large-scale analysis of real-world evidence is often limited to structured data
fields that do not contain reliable information on recurrence status and disease sites. In this …

To better define the biologic function of the type II insulin-like growth factor (IGF) receptor, we
raised a blocking antiserum in a rabbit by immunizing with highly purified rat type II IGF …

Objective: Clinical guidelines recommend that patients with HR+/HER2− metastatic breast
cancer (mBC), the most prevalent mBC subtype, receive three lines of endocrine therapy …

Use of Natural Language Processing to Assess Frequency of Functional Status Documentation
for Patients Newly Diagnosed With Colorectal Cancer | Colorectal Cancer | JAMA Oncology …